Patent details

Basic Information

Publication number:

EP2305302

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101830511

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

French Title of Invention:

PRÉVENTION ET TRAITEMENT DE MALADIE AMYLOIDOGÉNIQUE

German Title of Invention:

VORBEUGUNG UND BEHANDLUNG VON AMYLOIDOGENISCHEN KRANKHEITEN

SPC Number:

Dates

Filing date:

26/05/2000

Grant date:

20/12/2017

EP Publication Date:

06/04/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/12/2017

EP B1 Publication Date:

20/12/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/05/2018

Expiration date:

26/05/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/12/2017

 

 

Name:

Janssen Alzheimer Immunotherapy

Address:

Airton Road Tallaght, Dublin 24, Ireland (IE)

Inventor

1

Name:

Bard, Frederique

Address:

United States (US)

2

Name:

Yednock, Ted

Address:

United States (US)

3

Name:

Schenk, Dale B.

Address:

United States (US)

4

Name:

Vasquez, Nicki J.

Address:

United States (US)

Priority

Priority Number:

322289

Priority Date:

28/05/1999

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/17; A61K 39/00; A61K 39/39; A61K 39/395; A61K 48/00; A61P 25/28; C07K 14/47; G01N 33/68;

Publication

European Patent Bulletin

Issue number:

201751

Publication date:

20/12/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/09/2018	Outgoing Correspondence	1